Sep 2026
Integrin α2 (CD49b) blockade remodels the tumor immune microenvironment and enhances anti-PD-L1 therapy in 4T1 breast cancer model
I. Eissa, Yong-Tao Wang, Kenneth K. Tanabe
· Breast Cancer Research and T... · 0 citations